Article Text

Download PDFPDF
Letter
Direct to consumer advertising on websites of Peruvian naturopathic pharmacies
  1. Crislee E Lopez1,2,
  2. Stephanie Mosquera3,4,
  3. Álvaro Taype-Rondán5
  1. 1Comité Permanente Científico, Centro de Investigación y Estudios Médicos—CIEM, Arequipa, Perú
  2. 2School of Medicine, Universidad Católica de Santa María, Arequipa, Perú
  3. 3Sociedad Científica de Estudiantes de Medicina de la Universidad de San Martín de Porres, Lima, Perú
  4. 4School of Medicine, Universidad de San Martín de Porres, Lima, Perú
  5. 5CRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru
  1. Correspondence to Crislee E Lopez Colque, 5192, Calle Los naranjos 317—Alto Selva Alegre, Arequipa 5192, Perú; crisleelopez{at}gmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Direct-to-consumer advertising (DTCA) of pharmaceuticals is undertaken by pharmaceutical companies in order to encourage the consumption of medications. The US Food and Drug Administration (FDA) classifies DTCA into three types: (1) reminder advertisements contain the name of a drug only and are designed to reinforce brand recognition; (2) help-seeking advertisements contain information about a disease or condition without mentioning a particular treatment; (3) product-claim advertisements contain specifically effective and safe information about drug products and display ads that contain the names of them, indications, and information about their safety and effectiveness.1

Despite the importance of DTCA, there are no studies in naturopathic …

View Full Text

Footnotes

  • Twitter Follow CE Lopez at @CrisleeLopezC

  • Contributors CEL, SM and AT-R have participated in the design of the article, data collection, drafting, review and approval of the final version.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.